Blue Horseshoe Stocks: CAT Breakout & More

PetMed Express, Inc. PETS

We signaled a longer-term options idea for PETS yesterday which needs some time to ripen, but with the solid move in the stock itself, we figured we’d recap its performance since our initial alert on it six weeks ago.

We caught PETS at a low of 32.90, which makes its 43% run to 46.94 this week that much more impressive. For a thirty-dollar stock to gain more than a third of its value in a matter of just a few weeks, is no small feat.

We’ll continue to keep our selected options, the PETS 11/17 $40-50 Calls on watch over the next few weeks.


Caterpillar, Inc. CAT

Speaking of high dollar stocks that we’ve alerted and then gone on to see impressive gains, we’ve got CAT in our sights again this morning after a solid earnings beat. We’re going to want to highlight some options ideas here as well, but first, let’s talk about the incredible bullish run of Caterpillar this year.

We were talking about this stock back in March, and that same month, the stock traded for as little as 90.34, and has essentially been in a continual uptrend ever since. Measured to this morning’s new premarket high of 141.98, it represents an increase of 57% in just over six months.

As for the options we’ll want to track on the heels of CAT’s earnings beat this morning, we’ll be looking at the CAT Weekly $136-141 Calls.


Atossa Genetics, Inc. ATOS

We’d also like to quickly recap the respectable intraday performance recorded by ATOS following our alert on the stock yesterday morning.

From an early low of .50, ATOS ran to .636 for a solid 27% move which came on more than three times the monthly average volume.

On a side note, the company has also announced that it will hold a conference call tomorrow morning at 10am EDT to discuss preliminary results from the Phase I study of its proprietary oral Endoxifen, an active metabolite of the FDA-approved breast cancer drug tamoxifen. The conference call will be available through a live webcast at www.atossagenetics.com so we’ll be sure to tune in for that.


Extended Watchlist:
HMNY, RCON, ZYNE, KNL, CEMP, DXTR

Blue Horseshoe Stocks: QURE Recap & More

uniQure N.V. QURE

We included QURE in our premarket report on Thursday, after the company’s hemophilia gene therapy treatment was advanced to Phase III testing.

What followed was an enormous influx of volume, and two really solid, bullish sessions, advancing from a low of 11.55 on Thursday to a new high of 19.34 on Friday. That works out to a very respectable two-day swing of 67%

It’s the highest PPS QURE has attained since 2015, and the two sessions come in at numbers 1 and 2 highest volume days of all time, so we’d say our alert was timed with absolute precision.


Organovo Holdings, Inc. ONVO

We included ONVO in Friday morning’s extended watchlist, and it also put up a pretty good performance on the day.

From a low of 1.45, the stock traded as high as 1.80 on fairly heavy volume. We’ll want to see the stock continue to establish higher highs and higher lows as it’s coming off of its bottom.


PetMed Express, Inc. PETS

We’d like to signal a post-earnings options idea for PETS this morning, after the company set new records with its Q2 numbers. It’s gapping up significantly in the premarket, and the volume it traded on Friday leading into the release was the highest all month.  We’re going to put the PETS 11/17 $40-50 Calls on watch moving forward.


Extended Watchlist:
TISA, IMNP, LBIX, GEVO, KALV, ATNM, ATOS, XNET

Blue Horseshoe Stocks: NLNK Recap & More

NewLink Genetics Corp. NLNK

After our call of NLNK Thursday morning, the stock traded from 9.50-14.48 (+52%) which was a fantastic move for something it that price range.  We noted the strong close, and Friday morning re-iterated our interest despite the big move we’d already witnessed.

It’s a good thing we left NLNK on our radars, because while it didn’t quite rise to the previous session’s intraday performance, it came awfully close, and completed a very nice two-day swing for us in the process. Friday’s trading range on NLNK ran from 13.51 up to a new high of 19.30 for a daily move of 43% and representing a two-session rise of 103%

The stock traded thirteen times its monthly average volume, and maintained well over half its advance into a second consecutive strong close, so we’re quite curious to monitor its activity as we kick off a fresh trading week.


Kura Oncology Inc. KURA

Speaking of higher-priced movers, we also tagged KURA in Friday’s premarket report after the company’s mid-stage cancer treatment trials yielded positive results. It too went on a run which was uncharacteristically volatile for a $9+ stock.

The tradin grange on this one ran from 9.30-13.80 for an intraday push of 48% and did so on over 20X the monthly average volume. The close wasn’t quite as strong as the previously mentioned play, but we’ll still leave a slot open on our radar screens for KURA heading into this week.

______

Honorable Mention: Adaptimmune Therapeutics plc ADAP – While the level of gains provided wasn’t quite as high following our tag of ADAP on Thursday, the stock did string together a noteworthy couple of sessions. It traded from a low of 7.02 on Thursday to a high of 8.95 on Friday, marking a 27% swing.


Extended Watchlist:
MRNS, TEVA, BSMX, LINU, PETS